Medication infusion components and systems

    公开(公告)号:US12201752B2

    公开(公告)日:2025-01-21

    申请号:US17499612

    申请日:2021-10-12

    Abstract: This invention pertains to systems and components useful for infusing medications such as insulin. Typically, the components are used to deliver insulin to a diabetic patient at a site of infusion over a period of time greater than 4 days. The system components typically comprise a cannula adapted for subcutaneous insertion into a diabetic patient. The system further comprises a fluid conduit adapted to deliver the insulin solution from a medication reservoir to the site of infusion and a depot in operable contact with the fluid conduit. The depot comprises selected materials including a site-loss mitigating agent (such as heparin) which inhibits inflammation at the site of infusion, and encapsulation of the cannula at the site of infusion. The site-loss mitigating agent is not premixed with the insulin, and instead is adapted to contact the insulin solution in the depot as the insulin solution flows from the medication reservoir to the site of infusion.

    URINARY CATHETER KIT
    5.
    发明公开

    公开(公告)号:US20240082464A1

    公开(公告)日:2024-03-14

    申请号:US18263079

    申请日:2022-02-10

    CPC classification number: A61L29/085 A61L29/14

    Abstract: The present invention is directed to a urinary catheter kit comprising:—an aqueous lubricant composition comprising water and at least one polyether-polyurethane thermogelling copolymer P1, and —a urinary catheter with an external coating of thermogelling copolymer P2 comprising at least ether units.

Patent Agency Ranking